Growth • Catalyst Pharmaceuticals
CPRX
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
36,9%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
43,7%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
38,7%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
34,3%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
33,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
47,3%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!